Research Article10.1016/j.lungcan.2026.109096147 Review of patients with metastatic and locally advanced NSCLC who receive 2 years of palliative pembrolizumab with or without chemotherapyFeb 01, 2026Lung CancerMick Button + 9 more +9CiteListenSave
Research Article10.1016/j.lungcan.2026.109172224 Early Detection, Evolving Demand: Evaluating the impact of lung cancer screening on secondary care cancer servicesFeb 01, 2026Lung CancerKarim Abdeltawab + 8 more +8CiteListenSave
Research Article10.1016/j.lungcan.2026.109130182 The impact of non-cancer related mortality in patients who have undergone surgery for non-small cell lung cancerFeb 01, 2026Lung CancerLauren Devers + 5 more +5CiteListenSave
Research Article10.1016/j.lungcan.2026.109216268 Single centre experience of treatment and clinical outcomes of patients treated radically for limited-stage small cell lung cancerFeb 01, 2026Lung CancerYasmine Karachiwala + 3 more +3CiteListenSave
Research Article10.1016/j.lungcan.2026.10899546 Evaluation of Cardiology Investigations for Oncology Patients on Tyrosine Kinase InhibitorsFeb 01, 2026Lung CancerSrishti Agarwal + 9 more +9CiteListenSave
Research Article10.1016/j.lungcan.2026.109101153 A Retrospective Review of the Incidence and Management of Toxicities arising during Lorlatinib Treatment for Metastatic ALK gene fusion Non-Small Cell Lung Cancer (NSCLC) – Our Experience in a Mutationdriven Lung Cancer Clinic at The Clatterbridge Cancer Centre (CCC)Feb 01, 2026Lung CancerKyaw Zin Oo + 3 more +3CiteListenSave
Research Article10.1016/j.lungcan.2026.109193245 Herder Score Prediction of Malignancy in a Real-World ContextFeb 01, 2026Lung CancerMicayla Pather + 4 more +4CiteListenSave
Research Article10.1016/j.lungcan.2026.1089567 Role of Lung Genomics Coordinator/NavigatorFeb 01, 2026Lung CancerMayuri Basnet + 4 more +4CiteListenSave